Changes in the epidemic patterns of respiratory pathogens of children in guangzhou, China during the COVID-19 pandemic.

Publication date: Jul 01, 2025

To investigate the epidemiological characteristics of pediatric respiratory pathogens in Guangzhou, China, from 2018 to 2023 in the context of the COVID-19 Pandemic and to evaluate the impact of non-pharmaceutical interventions (NPIs) on the transmission dynamics and seasonal patterns of respiratory pathogens. A retrospective analysis was conducted at Guangzhou Women and Children’s Medical Center between January 2018 and December 2023. Pediatric patients who underwent the respiratory pathogens tests were enrolled in the study and divided into four groups by age: Infant group, Toddler group, Preschool group, and School-age group. The nasopharyngeal swab or bronchoalveolar lavage fluid (BALF) samples were collected for real-time fluorescence quantitative polymerase chain reaction (qPCR) test of respiratory pathogens. Ten common respiratory pathogens, including respiratory syncytial virus (RSV), Mycoplasma pneumoniae (MP) and Influenza A virus (FluA), were detected. In addition, the study period was divided into three phases: Pre-COVID-19 (2018-2019), COVID-19 (2020-2022), and Post-COVID-19 (2023). Detection rates, distribution patterns, and seasonal variations of respiratory pathogens were analyzed between different phases and different age groups. This study included 317,828 pediatric patients (median age: 3. 4 years, IQR: 1. 3-6. 0), from whom 1,160,764 respiratory pathogen tests were conducted. The overall pathogen detection rate was 8. 02% (93,108/1,160,764). The positive rate during the COVID-19 phase (18. 44%, 95% CI 14. 89-22. 00%) was significantly lower than that of the Pre-COVID-19 (27. 55%, 95% CI 23. 95-31. 16%) and Post-COVID-19 (27. 15, 95% CI 21. 47-32. 84%) phases (P 

Open Access PDF

Concepts Keywords
China Adolescent
Influenza Bronchoalveolar Lavage Fluid
Polymerase Child
Toddler Child, Preschool
Children
China
COVID-19
COVID-19
Epidemiological characteristics
Female
Humans
Infant
Infant, Newborn
Influenza A virus
Influenza, Human
Male
Mycoplasma pneumoniae
Nasopharynx
Non-Pharmaceutical interventions
Respiratory pathogens
Respiratory Tract Infections
Retrospective Studies
SARS-CoV-2
Seasons

Semantics

Type Source Name
disease MESH COVID-19 pandemic
drug DRUGBANK Pentaerythritol tetranitrate
drug DRUGBANK Influenza A virus
disease IDO pathogen
pathway REACTOME Reproduction
disease MESH Infectious Diseases
drug DRUGBANK Guanosine
drug DRUGBANK Coenzyme M
disease MESH Influenza
disease MESH Respiratory Syncytial Virus Infections
disease MESH Respiratory Tract Infections

Original Article

(Visited 2 times, 1 visits today)